You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR DSUVIA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for dsuvia

Trial ID Title Status Sponsor Phase Start Date Summary
NCT04387136 ↗ Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center Completed University of Minnesota Phase 4 2020-10-14 The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.
NCT04716413 ↗ Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Recruiting Montefiore Medical Center Phase 4 2021-05-01 In this case, series, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the PACU in ambulatory surgery patients taking Suboxone.
NCT05288348 ↗ DSUVIA Early Evaluation of Pain Trial Not yet recruiting United States Department of Defense Phase 3 2022-04-01 Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for dsuvia

Condition Name

Condition Name for dsuvia
Intervention Trials
Anesthesia 1
Pain 1
Pain, Acute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for dsuvia
Intervention Trials
Acute Pain 2
Wounds and Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for dsuvia

Trials by Country

Trials by Country for dsuvia
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for dsuvia
Location Trials
Pennsylvania 1
New York 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for dsuvia

Clinical Trial Phase

Clinical Trial Phase for dsuvia
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for dsuvia
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for dsuvia

Sponsor Name

Sponsor Name for dsuvia
Sponsor Trials
University of Minnesota 1
Montefiore Medical Center 1
United States Department of Defense 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for dsuvia
Sponsor Trials
Other 3
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.